Diagnostic logic and algorithm
The main challenge in recognizing rheumatic fever is that the clinical manifestations of this pathology are extremely nonspecific. Making an accurate diagnosis based solely on patient complaints is impossible.
To address this challenge, clinical practice employs a standardized system—the Jones diagnostic criteria. The basic principle of this system states: a diagnosis is considered valid only when the patient exhibits a specific combination of so-called "major" and "minor" criteria, which must be supported by evidence of the process's streptococcal etiology.
The diagnostic algorithm for "Acute Rheumatic Fever" considers it highly probable in the presence of confirmed infection combined with one of two options:
- Two "major" criteria.
- One "major" and two "minor" criteria.
Evidence of streptococcal infection
Confirmation of prior infection is an absolute prerequisite. Without it, linking current symptoms to rheumatic fever is impossible. The evidence base relies on two main approaches:
- Bacteriological confirmation
Based on isolating group A beta-hemolytic streptococcus (GABHS) from the patient's pharynx. Important clinical nuance: a single throat culture is positive in only 20–45% of cases. To significantly increase the diagnostic yield, serial cultures must be performed.
- Serological confirmation (assessment of the immune response)
Consists of recording elevated titers of specific antistreptococcal antibodies. This marker is detected in approximately 2/3 of patients. The main evaluated parameters include:
- Antistreptolysin-O (ASO);
- Antistreptokinase;
- Antistreptohyaluronidase;
- Anti-DNase B antibodies (a titer > 1:250 is considered diagnostically significant).
Serological markers play a key role: they not only confirm the presence of infection but also indicate its activity, which is critically crucial for diagnosing disease exacerbations.
Principles of complex treatment
Therapeutic tactics for rheumatic fever are comprehensive and strictly divided into three sequential stages: etiotropic, pathogenetic, and prophylactic.
Etiotropic therapy Aimed at complete eradication (destruction) of the pathogen—beta-hemolytic streptococcus. The drug of choice at this stage is penicillin, prescribed in a standard course lasting 10 to 14 days.
Pathogenetic therapy Its main goal is halting the inflammatory process. The choice of a specific drug group depends directly on the degree of inflammation activity:
- In severe inflammation, glucocorticosteroids are used (e.g., prednisolone at a dosage of 20–30 mg daily). An important condition is the subsequent gradual, controlled tapering of the drug dose.
- In less severe inflammation, the use of nonsteroidal anti-inflammatory drugs (NSAIDs) is sufficient.
Prophylaxis The final yet longest stage, aimed at preventing disease recurrences (secondary prophylaxis).
Secondary prophylaxis of rheumatic fever
The main goal of secondary prophylaxis is reliable prevention of recurrent attacks of rheumatic fever, as well as preventing new episodes of streptococcal infection. This is necessary to halt the progression of heart valve defects that have already formed in the patient.
The methodology consists of regular, monthly intramuscular injections of prolonged-action penicillins. The standard drug for these purposes is Bicillin-5, a combined agent containing benzathine benzylpenicillin and procaine benzylpenicillin.
Briefly: answers to topical questions
What are the "major" Jones diagnostic criteria for acute rheumatic fever?
In acute rheumatic fever, five "major" diagnostic criteria are distinguished. They reflect specific manifestations of the disease and involvement of major target organs:
- Carditis — inflammation of the heart layers, including valvulitis.
- Polyarthritis — inflammatory involvement primarily of large joints.
- Chorea — specific involvement of the nervous system.
- Erythema marginatum (erythema annulare/marginatum) — characteristic skin lesion.
- Subcutaneous nodules — rheumatic nodules located subcutaneously.
What "minor" Jones diagnostic criteria are considered in diagnosing rheumatic fever?
The "minor" diagnostic criteria for rheumatic fever serve as additional markers of inflammation and include nonspecific clinical, laboratory, and instrumental signs. These include:
- Clinical signs — fever and arthralgia (joint pain without objective signs of inflammation).
- Laboratory signs — elevated acute-phase reactants (accelerated ESR, elevated C-reactive protein levels), as well as leukocytosis.
- Instrumental signs — prolongation of the P-Q (or P-R) interval on the ECG, indicating impaired atrioventricular conduction.
Which specific nonsteroidal anti-inflammatory drugs (NSAIDs) are used in the treatment of rheumatic fever?
The provided sources on acute rheumatic fever do not list specific NSAID medications. It is indicated that NSAIDs are used as part of pathogenetic anti-inflammatory therapy in cases of less severe inflammation.
In severe inflammation, glucocorticosteroids are used instead of NSAIDs: prednisolone 20–30 mg/day followed by gradual dose tapering.
Diagnosis formula: "Streptococcus + 2 Majors" OR "Streptococcus + 1 Major + 2 Minors".
Class and exam questions
Why is it impossible to make a diagnosis based solely on the patient's complaints?
Clinical manifestations of acute rheumatic fever are nonspecific. For accurate diagnosis, it is necessary to apply standardized Jones criteria and necessarily confirm the link to streptococcal infection.
Is it sufficient to take a single throat swab to detect streptococcus?
No, a single bacteriological culture is informative in only 20–45% of cases. For reliable isolation of group A beta-hemolytic streptococcus, serial cultures are required.
How is a drug chosen for pathogenetic therapy?
The choice depends on the process activity: glucocorticosteroids (prednisolone 20–30 mg/day) are prescribed for pronounced inflammation, while nonsteroidal anti-inflammatory drugs are used for less intense inflammation.
What is the purpose of secondary prevention with Bicillin-5?
Monthly administration of prolonged penicillins prevents recurrent infection attacks, which is vital for protecting heart valves from the formation and progression of valve defects.
What else to study on this topic
- Detailed list of "major" Jones criteria
- List and clinical significance of "minor" diagnostic criteria
- Regimens and rules for gradual glucocorticosteroid tapering
- Mechanisms of acquired heart defect development in rheumatism
Master the entire topic in the "Propaedeutics" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Rheumatic fever: diagnosis and treatment" and 3,152 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 113 video lessons on the subject
Other topics in the "Cardiovascular system" section
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.